PE20100716A1 - Proceso para la sintesis de 1-bromo-3-nitro-5-trifluorometil-benceno - Google Patents

Proceso para la sintesis de 1-bromo-3-nitro-5-trifluorometil-benceno

Info

Publication number
PE20100716A1
PE20100716A1 PE2010000468A PE2010000468A PE20100716A1 PE 20100716 A1 PE20100716 A1 PE 20100716A1 PE 2010000468 A PE2010000468 A PE 2010000468A PE 2010000468 A PE2010000468 A PE 2010000468A PE 20100716 A1 PE20100716 A1 PE 20100716A1
Authority
PE
Peru
Prior art keywords
nitro
bromo
trifluorometil
benzeno
synthesis
Prior art date
Application number
PE2010000468A
Other languages
English (en)
Spanish (es)
Inventor
Stephan Abel
Murat Acemoglu
Bernhard Erb
Christoph Krell
Joseph Sclafani
Mark Meisenbach
Mahavir Prashad
Wen-Chung Shieh
Song Xue
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=37149980&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PE20100716(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of PE20100716A1 publication Critical patent/PE20100716A1/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C205/00Compounds containing nitro groups bound to a carbon skeleton
    • C07C205/07Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by halogen atoms
    • C07C205/11Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by halogen atoms having nitro groups bound to carbon atoms of six-membered aromatic rings
    • C07C205/12Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by halogen atoms having nitro groups bound to carbon atoms of six-membered aromatic rings the six-membered aromatic ring or a condensed ring system containing that ring being substituted by halogen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • C07D233/61Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms with hydrocarbon radicals, substituted by nitrogen atoms not forming part of a nitro radical, attached to ring nitrogen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
PE2010000468A 2005-06-09 2006-06-07 Proceso para la sintesis de 1-bromo-3-nitro-5-trifluorometil-benceno PE20100716A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US68897605P 2005-06-09 2005-06-09

Publications (1)

Publication Number Publication Date
PE20100716A1 true PE20100716A1 (es) 2010-10-25

Family

ID=37149980

Family Applications (3)

Application Number Title Priority Date Filing Date
PE2010000468A PE20100716A1 (es) 2005-06-09 2006-06-07 Proceso para la sintesis de 1-bromo-3-nitro-5-trifluorometil-benceno
PE2010000467A PE20100715A1 (es) 2005-06-09 2006-06-07 Proceso para la sintesis de 5-(4-metil-1h-imidazol-1-il)-3-(trifluorometil)-bencenamina
PE2006000628A PE20070109A1 (es) 2005-06-09 2006-06-07 Procesos para la sintesis de 5-(4-metil-1h-imidazol-1-il)-3-(trifluorometil)-bencenamina

Family Applications After (2)

Application Number Title Priority Date Filing Date
PE2010000467A PE20100715A1 (es) 2005-06-09 2006-06-07 Proceso para la sintesis de 5-(4-metil-1h-imidazol-1-il)-3-(trifluorometil)-bencenamina
PE2006000628A PE20070109A1 (es) 2005-06-09 2006-06-07 Procesos para la sintesis de 5-(4-metil-1h-imidazol-1-il)-3-(trifluorometil)-bencenamina

Country Status (25)

Country Link
US (2) US7781597B2 (2)
EP (3) EP1896426B1 (2)
JP (2) JP5225078B2 (2)
KR (2) KR101283109B1 (2)
CN (6) CN102180836B (2)
AR (1) AR057056A1 (2)
AT (1) ATE540931T1 (2)
AU (3) AU2006258050B2 (2)
BR (1) BRPI0611683A2 (2)
CA (4) CA2611280C (2)
DK (2) DK2266961T3 (2)
ES (3) ES2380489T3 (2)
GT (1) GT200600202AA (2)
HU (1) HUE028024T2 (2)
IN (2) IN2014DN08578A (2)
JO (1) JO2758B1 (2)
MX (1) MX2007015609A (2)
MY (1) MY146795A (2)
PE (3) PE20100716A1 (2)
PL (3) PL2292607T3 (2)
PT (3) PT1896426E (2)
RU (1) RU2446162C2 (2)
SI (2) SI2266961T1 (2)
TW (1) TWI380981B (2)
WO (1) WO2006135640A2 (2)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2005219788B2 (en) 2004-03-05 2010-06-03 Nissan Chemical Corporation Isoxazoline-substituted benzamide compound and noxious organism control agent
MY146795A (en) * 2005-06-09 2012-09-28 Novartis Ag Process for the synthesis of organic compounds
TW200803740A (en) 2005-12-16 2008-01-16 Du Pont 5-aryl isoxazolines for controlling invertebrate pests
TWI412322B (zh) 2005-12-30 2013-10-21 Du Pont 控制無脊椎害蟲之異唑啉
AU2008261793A1 (en) 2007-06-13 2008-12-18 E. I. Du Pont De Nemours And Company Isoxazoline insecticides
TWI430995B (zh) 2007-06-26 2014-03-21 Du Pont 萘異唑啉無脊椎有害動物控制劑
ES2549731T3 (es) 2007-06-27 2015-11-02 E. I. Du Pont De Nemours And Company Método para el control de plagas en animales
TWI649303B (zh) 2007-08-17 2019-02-01 杜邦股份有限公司 製備4-乙醯基-n-〔2-側氧基-2-〔(2,2,2-三氟乙基)胺基〕乙基〕-1-萘甲醯胺之化合物及方法
US8367584B2 (en) 2007-10-03 2013-02-05 E.I. Du Pont De Nemours And Company Naphthalene isoxazoline compounds for control of invertebrate pests
TWI518076B (zh) 2008-04-09 2016-01-21 杜邦股份有限公司 製備雜環化合物之方法
EP2305667A3 (en) 2008-07-17 2011-05-11 Teva Pharmaceutical Industries Ltd. Nilotinib intermediates and preparation thereof
WO2010054056A2 (en) 2008-11-05 2010-05-14 Teva Pharmaceutical Industries Ltd. Nilotinib hci crystalline forms
WO2010060074A1 (en) * 2008-11-24 2010-05-27 Teva Pharmaceutical Industries Ltd. Preparation of nilotinib and intermediates thereof
US20110053968A1 (en) * 2009-06-09 2011-03-03 Auspex Pharmaceuticals, Inc. Aminopyrimidine inhibitors of tyrosine kinase
RS54677B1 (sr) 2010-05-27 2016-08-31 E. I. Du Pont De Nemours And Company Kristalni oblici 4-[5-[3-hloro-5-(trifluorometil)fenil]-4,5 -dihidro-5-(trifluorometil)-3-izoksazolil]-n-[2-okso-2-[(2,2,2-trifluoroetil)amino]etil]-1-naftalenkarboksamida
BR112014015720B1 (pt) 2011-12-30 2020-03-17 Hanmi Pharm. Co., Ltd. Derivados de tieno[3,2-d]pirimidina, composição farmacêutica e uso dos mesmos para a prevenção ou tratamento de uma doença causada por ativação anormal de uma proteína quinase
CN102592837B (zh) * 2012-03-12 2014-01-15 河北师范大学 制备超级电容器用四氯合金属季铵盐掺杂聚苯胺电极的方法
CN103694176B (zh) * 2014-01-07 2015-02-18 苏州立新制药有限公司 尼洛替尼中间体的制备方法
CN104592122B (zh) * 2014-12-09 2018-01-23 凯莱英医药集团(天津)股份有限公司 3‑(4‑甲基‑1h‑咪唑‑1‑基)‑5‑(三氟甲基)苯胺的制备方法
CN105985293B (zh) * 2015-03-04 2018-04-03 埃斯特维华义制药有限公司 尼洛替尼中间体的制备方法
EP3095782A1 (en) 2015-05-18 2016-11-23 Esteve Química, S.A. New method for preparing 3-(4-methyl-1h-imidazol-1-yl)-5-(trifluoromethyl)benzenamine
CN107201532B (zh) * 2017-05-09 2019-08-27 吉林凯莱英医药化学有限公司 芳香化合物的硝化方法
US11053220B2 (en) 2018-01-01 2021-07-06 Laurus Labs Ltd Process for 3-(4-methyl-1H-imidazol-1-yl)-5-(trifluoromethyl) aniline
CN108530364B (zh) 2018-04-10 2020-01-21 江苏创诺制药有限公司 一种3-(4-甲基-1h-咪唑-1-基)-5-三氟甲基苯胺单盐酸盐的晶型及其应用
TWI831259B (zh) 2018-06-15 2024-02-01 漢達生技醫藥股份有限公司 包含達沙替尼十二烷基硫酸鹽組合物的膠囊
EP3953336A4 (en) * 2019-04-06 2023-05-03 Trinapco, Inc SULFONYLDIAZOLES AND N-(FLUOROSULFONYL)AZOLES, AND METHODS FOR THE PREPARATION THEREOF
EP3904342A1 (en) 2020-04-28 2021-11-03 Grindeks, A Joint Stock Company Process for the preparation of 3-(trifluoromethyl)-5-(4-methyl-1h-imidazole-1-yl)-benzeneamine hydrochloride
CN114751836B (zh) * 2021-02-23 2024-05-31 四川青木制药有限公司 3-(4-甲基-1h-咪唑-1-基)-5-(三氟甲基)苯胺合成方法及其中间体
CN114853734A (zh) * 2022-06-14 2022-08-05 海南鑫开源医药科技有限公司 一种尼洛替尼游离碱的制备方法
CN116478319B (zh) * 2022-11-07 2025-07-01 华北电力大学 一种离子共价有机聚合物的制备方法及其在碱性环境吸附ReO4-的应用
CN115626880B (zh) * 2022-11-15 2023-11-14 常州大学 3-硝基-5-氰基三氟甲苯的合成方法
CN118108670B (zh) * 2023-12-28 2025-07-01 江苏希迪制药有限公司 尼罗替尼中间体3-(4-甲基-1h-咪唑-1-基)-5-(三氟甲基)苯胺的精制纯化方法
CN121517361A (zh) * 2026-01-15 2026-02-13 湖南阿斯迪康药业有限公司 一种基于溴苯类化合物合成1-芳基咪唑类化合物的方法

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SU1051076A1 (ru) * 1982-04-09 1983-10-30 Алтайский политехнический институт Способ получени производных имидазола
GB8413685D0 (en) * 1984-05-29 1984-07-04 Pfizer Ltd Quinolone inotropic agents
CA1292234C (en) * 1984-05-29 1991-11-19 Simon Fraser Campbell Heterocyclic-substituted quinolone inotropic agents
GB8502267D0 (en) * 1985-01-30 1985-02-27 Pfizer Ltd Quinolone inotropic agents
HN2001000008A (es) * 2000-01-21 2003-12-11 Inc Agouron Pharmaceuticals Compuesto de amida y composiciones farmaceuticas para inhibir proteinquinasas, y su modo de empleo
GB0023383D0 (en) * 2000-09-23 2000-11-08 Synprotec Ltd 3,5-Bis (Trifluormethyl)Benzene derivatives
PE20040522A1 (es) * 2002-05-29 2004-09-28 Novartis Ag Derivados de diarilurea dependientes de la cinasa de proteina
GB0215676D0 (en) * 2002-07-05 2002-08-14 Novartis Ag Organic compounds
GB0222514D0 (en) * 2002-09-27 2002-11-06 Novartis Ag Organic compounds
CN1939910A (zh) 2004-12-31 2007-04-04 孙飘扬 氨基嘧啶类化合物及其盐和其制备方法与药物用途
GT200600207A (es) * 2005-06-09 2007-01-15 Novartis Ag Proceso para la síntesis de compuestos orgánicos
MY146795A (en) * 2005-06-09 2012-09-28 Novartis Ag Process for the synthesis of organic compounds

Also Published As

Publication number Publication date
AU2006258050A1 (en) 2006-12-21
EP2266961B1 (en) 2015-10-21
CA2833394C (en) 2016-03-29
AU2006258050B2 (en) 2010-12-09
JP5225078B2 (ja) 2013-07-03
EP1896426A2 (en) 2008-03-12
KR101249199B1 (ko) 2013-04-03
CN102174019B (zh) 2013-02-13
PT2292607E (pt) 2014-06-24
US7781597B2 (en) 2010-08-24
CN101189212A (zh) 2008-05-28
PL2266961T3 (pl) 2016-04-29
PT2266961E (pt) 2016-02-05
ATE540931T1 (de) 2012-01-15
WO2006135640A2 (en) 2006-12-21
KR20120099028A (ko) 2012-09-06
CN102174020A (zh) 2011-09-07
CA2886482C (en) 2017-09-05
JP2008546645A (ja) 2008-12-25
CN102174019A (zh) 2011-09-07
CN102174020B (zh) 2012-11-07
MY146795A (en) 2012-09-28
CA2833394A1 (en) 2006-12-21
SI2292607T1 (sl) 2014-09-30
EP2292607A3 (en) 2011-04-27
ES2558696T3 (es) 2016-02-08
KR101283109B1 (ko) 2013-07-05
CN102180836B (zh) 2012-11-21
EP2292607B1 (en) 2014-04-09
PL1896426T3 (pl) 2012-06-29
US8008504B2 (en) 2011-08-30
WO2006135640A3 (en) 2007-08-02
PE20100715A1 (es) 2010-10-25
US20080200692A1 (en) 2008-08-21
CA2611280A1 (en) 2006-12-21
TWI380981B (zh) 2013-01-01
CA2611280C (en) 2014-01-28
RU2446162C2 (ru) 2012-03-27
JP2013035855A (ja) 2013-02-21
JO2758B1 (en) 2014-03-15
EP1896426B1 (en) 2012-01-11
IN2014DN08588A (2) 2015-07-10
HUE028024T2 (en) 2016-11-28
TW200716563A (en) 2007-05-01
RU2007148238A (ru) 2009-07-20
KR20080014010A (ko) 2008-02-13
MX2007015609A (es) 2008-02-25
CA2942046A1 (en) 2006-12-21
AU2010241374A1 (en) 2010-12-02
AU2011201044A1 (en) 2011-03-31
ES2465522T3 (es) 2014-06-06
GT200600202AA (es) 2014-06-09
PE20070109A1 (es) 2007-04-02
SI2266961T1 (sl) 2016-02-29
EP2292607A2 (en) 2011-03-09
DK2292607T3 (da) 2014-06-30
CN102180836A (zh) 2011-09-14
US20100280257A1 (en) 2010-11-04
EP2266961A2 (en) 2010-12-29
PL2292607T3 (pl) 2014-09-30
EP2266961A3 (en) 2011-07-27
DK2266961T3 (en) 2016-01-25
CN102174021B (zh) 2013-02-27
ES2380489T3 (es) 2012-05-14
AR057056A1 (es) 2007-11-14
AU2010241374B2 (en) 2011-11-03
CA2886482A1 (en) 2006-12-21
CN102180796A (zh) 2011-09-14
IN2014DN08578A (2) 2015-07-10
PT1896426E (pt) 2012-04-12
CN101189212B (zh) 2011-05-18
BRPI0611683A2 (pt) 2010-09-28
CN102174021A (zh) 2011-09-07
ES2380489T8 (es) 2012-06-22

Similar Documents

Publication Publication Date Title
PE20100716A1 (es) Proceso para la sintesis de 1-bromo-3-nitro-5-trifluorometil-benceno
UY28968A1 (es) (orto-fenil)-anilidas de ácido 1-metil-3-trifluorometil-pirazol-4-carboxílico y su uso como fungicida
NZ735019A (en) Molecules having pesticidal utility, and intermediates, compositions, and processes, related thereto
BRPI0615705A2 (pt) processo para preparar um composto, e, composto
WO2008027264A3 (en) Disinfectant systems and methods
EA200901609A1 (ru) Амиды пиразолкарбоновой кислоты, применимые в качестве микробиоцидов
MX2011009131A (es) Composiciones aditivas espesantes.
NZ720067A (en) Disinfectant composition
CL2012000560A1 (es) Procedimiento de preparacion del compuesto intermediario acido 3-oxo-tetrahidrotiofeno-2-carboxilico, utiles en la preparacion de dihidrotienopirimidinas (divisional de la solicitud 3095-08).
BR112013012795B8 (pt) processo de tratamento de produtos vegetais e composição
UA106880C2 (uk) Нові гербіциди
BR112018001863A2 (pt) ?processo para a preparação de n- [2 - [[[1- (4-clorofenil) -1h-pirazol-3-il] oxi] metil] fenil]?
BRPI0610644B8 (pt) composto e composição farmacêutica que compreende tal composto e um veículo ou diluente farmaceuticamente aceitável.
NZ739853A (en) Molecules having pesticidal utility, and intermediates, compositions, and processes, related thereto
AR064658A1 (es) Proceso para preparar duloxetina y sus compuestos relacionados, asi como tambien intermediarios utiles en la misma
UA103460C2 (ru) СПОСОБ ПОЛУЧЕНИЯ D-(-)-N,N-ДИЭТИЛ-2-(α-НАФТОКСИ)ПРОПИОНАМИДА
MX2017015606A (es) Proceso para preparar 3-metilciclopentadecan-1,5-diona.
MX2009012231A (es) Formulaciones de cinamaldehido y metodos de uso.
CO6341474A2 (es) Formas solidas de (1r,2s,3r)-1-(2-isoxazol-3-il)-1h-imidazol-4-il) butano-1,2,3,4-tetraol y metodos para su uso
BR112012014347A2 (pt) processo de epoxidação e microestrutura
BR112021018733A2 (pt) Composições de d-metirosina e métodos para preparar as mesmas
CL2008003553A1 (es) Proceso para preparar atipamezol o clorhidrato de 5-(2-etil-2,3-dihidro-1h-inden-2-il)-1h-imidazol: y loa compuestos intermediarios considerados en el proceso
AR073807A1 (es) Proceso para preparar el malato de sunitinib, sal de un acido mas debil que el malato como compuesto intermediario, y proceso para preparar dicha sal intermediaria.
PE20070084A1 (es) Proceso para la sintesis de 5-(4-metil-1h-imidazol-1-il)-3-(trifluoro-metil)-bencenamina
BRPI0622430A2 (pt) processo para produzir fluoretos de ácido 5-flúor-1,3-dialquil-1h-pirazol-4-carboxílico

Legal Events

Date Code Title Description
FG Grant, registration
FD Application declared void or lapsed